Vagus Nerve Stimulation Therapy after Failed Cranial Surgery for Intractable Epilepsy: Results from the Vagus Nerve Stimulation Therapy Patient Outcome Registry
Authors:
- 1 November 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 55 (5) , 1086-1093
Abstract
OBJECTIVE: To determine the effectiveness of vagus nerve stimulation (VNS) therapy among patients with persistent or recurrent seizures after lobar resection, callosotomy, and other cranial operations for intractable epilepsy. METHODS: Data were obtained from the VNS therapy patient outcome registry, which was established after United States Food and Drug Administration approval of the VNS device in 1997 as a means of capturing open-label clinical data outside of protocol. The integrity of the systems for collecting and processing registry data was authenticated by an independent auditing agency. The effect of potential selection bias, however, remains uncertain. RESULTS: Two nonconsecutive cohorts were compared: patients tracked in the registry who had previously undergone cranial surgery for epilepsy (CS group, n = 921) and those who had not (non-CS group, n = 3822). For the CS group, the median reduction in seizure frequency was 42.5% after 3 months of VNS therapy, 42.9% at 6 months, 45.7% at 12 months, 52.0% at 18 months, and 50.5% at 24 months. For the non-CS group, analogous rates were 47.0%, 52.9%, 60.0%, 62.7%, and 66.7%, respectively. In the CS group, seizures were reduced by at least 50% in 55.1% of patients, at least 75% in 31.4% of patients, at least 90% in 17.3% of patients, and 100% in 5.1% of patients after 24 months of VNS therapy. Response rates were more pronounced in the non-CS group: at least 50% in 62.2% of patients, at least 75% in 43.7% of patients, at least 90% in 26.8% of patients, and 100% in 8.3% of patients. Patients in both groups experienced marked improvements in quality of life parameters. CONCLUSION: The effectiveness of VNS is maintained during prolonged stimulation, and overall seizure control continues to improve with time. Patients in whom prior cranial surgery had failed did not respond as favorably as all other patients receiving VNS therapy. Nonetheless, many of the former group improved substantially. Thus, on the basis of these open-label data, VNS therapy represents a potentially palliative treatment option for patients with refractory seizures after failed cranial surgery.Keywords
This publication has 28 references indexed in Scilit:
- Long-term treatment with vagus nerve stimulation in patients with refractory epilepsyNeurology, 1999
- Vagus Nerve StimulationEpilepsia, 1998
- Surgical and Neurological Complications in a Series of 708 Epilepsy Surgery ProceduresNeurosurgery, 1997
- Vagus Nerve Stimulation Activates Central Nervous System Structures in Epileptic Patients During PET H215O Blood Flow ImagingNeurosurgery, 1996
- Surgery for SeizuresNew England Journal of Medicine, 1996
- Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerveEpilepsy Research, 1995
- Reevaluation of Surgical Failures and the Role of Reoperation in 39 Patients with Frontal Lobe EpilepsyEpilepsia, 1994
- Second Operation after the Failure of Previous Resection for EpilepsyNeurosurgery, 1991
- Anatomical, Physiological, and Theoretical Basis for the Antiepileptic Effect of Vagus Nerve StimulationEpilepsia, 1990
- Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the ratBrain Research, 1978